Citations (108)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (19)
Dahiana M. Gallo, Wendy Fitzgerald, Roberto Romero, Nardhy Gomez-Lopez, Dereje W. Gudicha, Nándor Gábor Than, Mariachiara Bosco, Tinnakorn Chaiworapongsa, Eunjung Jung, Arun Meyyazhagan, Manaphat Suksai, Francesca Gotsch, Offer Erez, Adi L. Tarca & Leonid Margolis. (2023) Proteomic profile of extracellular vesicles in maternal plasma of women with fetal death. The Journal of Maternal-Fetal & Neonatal Medicine 36:1.
Read now
Read now
Sun Kwon Kim, Sangeetha Vishweswaraiah, Jacqueline Macknis, Ali Yilmaz, Ashna Lalwani, Nitish K. Mishra, Chittibabu Guda, Dotun Ogunyemi, Uppala Radhakrishna & Ray O. Bahado-Singh. (2022) New-onset postpartum preeclampsia: epigenetic mechanism and prediction. The Journal of Maternal-Fetal & Neonatal Medicine 35:25, pages 7179-7187.
Read now
Read now
Ying Wang, Na Wu & Haitao Shen. (2021) A Review of Research Progress of Pregnancy with Twins with Preeclampsia. Risk Management and Healthcare Policy 14, pages 1999-2010.
Read now
Read now
Nikolina Docheva, Roberto Romero, Piya Chaemsaithong, Adi L. Tarca, Gaurav Bhatti, Percy Pacora, Bogdan Panaitescu, Noppadol Chaiyasit, Tinnakorn Chaiworapongsa, Eli Maymon, Sonia S. Hassan & Offer Erez. (2019) The profiles of soluble adhesion molecules in the “great obstetrical syndromes”*. The Journal of Maternal-Fetal & Neonatal Medicine 32:13, pages 2113-2136.
Read now
Read now
Ahmed M. Abbas, Engy M. Fikry, Taha S. Mostafa, Asmaa S. Shaltout & Mona A.H. El-Baz. (2018) Prognostic value of serum soluble FMS-like tyrosine kinase (sFlt-1) levels in pre-eclampsia and eclampsia; a prospective cohort study. Hypertension in Pregnancy 37:3, pages 137-143.
Read now
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Amy E. Whitten, Steven J. Korzeniewski, Piya Chaemsaithong, Edgar Hernandez-Andrade, Lami Yeo & Sonia S. Hassan. (2016) The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 29:8, pages 1214-1228.
Read now
Read now
Piya Chaemsaithong, Roberto Romero, Adi L. Tarca, Steven J. Korzeniewski, Alyse G. Schwartz, Jezid Miranda, Ahmed I. Ahmed, Zhong Dong, Sonia S. Hassan, Lami Yeo & Tinnakorn Tinnakorn. (2015) Maternal plasma fetuin-A concentration is lower in patients who subsequently developed preterm preeclampsia than in uncomplicated pregnancy: a longitudinal study. The Journal of Maternal-Fetal & Neonatal Medicine 28:11, pages 1260-1269.
Read now
Read now
Tiffany A. Moore Simas, Sybil L. Crawford, Susanne Bathgate, Jing Yan, Laura Robidoux, Melissa Moore & Sharon E. Maynard. (2014) Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women. The Journal of Maternal-Fetal & Neonatal Medicine 27:10, pages 1038-1048.
Read now
Read now
Piya Chaemsaithong, Tinnakorn Chaiworapongsa, Roberto Romero, Steven J. Korzeniewski, Tamara Stampalija, Nandor Gabor Than, Zhong Dong, Jezid Miranda, Lami Yeo & Sonia S. Hassan. (2014) Maternal plasma soluble TRAIL is decreased in preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 27:3, pages 217-227.
Read now
Read now
Tinnakorn Chaiworapongsa, Roberto Romero, Steven J. Korzeniewski, Josef M. Cortez, Athina Pappas, Adi L. Tarca, Piya Chaemsaithong, Zhong Dong, Lami Yeo & Sonia S. Hassan. (2014) Plasma concentrations of angiogenic/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study. The Journal of Maternal-Fetal & Neonatal Medicine 27:2, pages 132-144.
Read now
Read now
Tamara Stampalija, Tinnakorn Chaiworapongsa, Roberto Romero, Piya Chaemsaithong, Steven J. Korzeniewski, Alyse G. Schwartz, Enrico M. Ferrazzi, Zhong Dong & Sonia S. Hassan. (2013) Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 26:14, pages 1359-1370.
Read now
Read now
Nikolaos Vrachnis, Emmanouil Kalampokas, Stavros Sifakis, Nikolaos Vitoratos, Theodoros Kalampokas, Demetrios Botsis & Zoe Iliodromiti. (2013) Placental growth factor (PlGF): a key to optimizing fetal growth. The Journal of Maternal-Fetal & Neonatal Medicine 26:10, pages 995-1002.
Read now
Read now
Shin Young Kim, So Yeon Park, Mi Jin Kim, Bom Yi Lee, Jung Yeol Han & Hyun Mee Ryu. (2013) Preeclampsia is associated with an elevation of plasma sMet concentrations in the second trimester. The Journal of Maternal-Fetal & Neonatal Medicine 26:9, pages 860-865.
Read now
Read now
Sarosh Rana, William T. Schnettler, Camille Powe, Julia Wenger, Saira Salahuddin, Ana Sofia Cerdeira, Stefan Verlohren, Frank H. Perschel, Zoltan Arany, Kee-Hak Lim, Ravi Thadhani & S. Ananth Karumanchi. (2013) Clinical characterization and outcomes of preeclampsia with normal angiogenic profile. Hypertension in Pregnancy 32:2, pages 189-201.
Read now
Read now
Tamar Eshkoli, Gershon Holcberg, Bella Bronfenmacher, Alaa Amash, Mahmoud Huleihel & Offer Erez. (2013) Perfusion with magnesium sulfate increases sFlt-1 secretion only in the fetal side of placenta of women with preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 26:2, pages 116-122.
Read now
Read now
Andreea G. Moore, Heather Young, Jennifer M. Keller, Linda R. Ojo, Jing Yan, Tiffany A. Moore Simas & Sharon E. Maynard. (2012) Angiogenic biomarkers for prediction of maternal and neonatal complications in suspected preeclampsia. The Journal of Maternal-Fetal & Neonatal Medicine 25:12, pages 2651-2657.
Read now
Read now
Jimmy Espinoza. (2012) The need to redefine preeclampsia. Expert Opinion on Medical Diagnostics 6:4, pages 347-357.
Read now
Read now
Asim Duttaroy & Sanjay Basak. (2012) Docosahexaenoic acid and angiogenesis: a role in early placentation. Clinical Lipidology 7:3, pages 303-312.
Read now
Read now
Jimmy Espinoza. (2012) Recent biomarkers for the identification of patients at risk for preeclampsia: the role of uteroplacental ischemia. Expert Opinion on Medical Diagnostics 6:2, pages 121-130.
Read now
Read now
Articles from other publishers (89)
Tinnakorn Chaiworapongsa, Roberto Romero, Nardhy Gomez-Lopez, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Stanley M. Berry, Awoniyi Awonuga, Adi L. Tarca & David R. Bryant. (2023) Preeclampsia at term: evidence of disease heterogeneity based on the profile of circulating cytokines and angiogenic factors. American Journal of Obstetrics and Gynecology.
Crossref
Crossref
Piya Chaemsaithong, María M. Gil, Noppadol Chaiyasit, Diana Cuenca-Gomez, Walter Plasencia, Valeria Rolle & Liona C. Poon. (2023) Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis. American Journal of Obstetrics and Gynecology 229:3, pages 222-247.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Francesca Gotsch, Nardhy Gomez-Lopez, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Dustyn Levenson & Adi L. Tarca. (2023) One-third of patients with eclampsia at term do not have an abnormal angiogenic profile. Journal of Perinatal Medicine 51:5, pages 652-663.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Francesca Gotsch, Manaphat Suksai, Dahiana M. Gallo, Eunjung Jung, Arthur Krieger, Piya Chaemsaithong, Offer Erez & Adi L. Tarca. (2023) Preeclampsia at term can be classified into 2 clusters with different clinical characteristics and outcomes based on angiogenic biomarkers in maternal blood. American Journal of Obstetrics and Gynecology 228:5, pages 569.e1-569.e24.
Crossref
Crossref
Xiangzhou Zeng, Siyu Li, Lu Liu, Shuang Cai, Qianhong Ye, Bangxin Xue, Xinyu Wang, Shihai Zhang, Fang Chen, Chuanjiang Cai, Fenglai Wang & Xiangfang Zeng. (2023) Role of functional fatty acids in modulation of reproductive potential in livestock. Journal of Animal Science and Biotechnology 14:1.
Crossref
Crossref
Sanjay Basak & Asim K. Duttaroy. (2022) Maternal PUFAs, Placental Epigenetics, and Their Relevance to Fetal Growth and Brain Development. Reproductive Sciences 30:2, pages 408-427.
Crossref
Crossref
Sultan Şalk, Nazan Yurtcu & Ali Çetin. (2022) Predictive and diagnostic value of serum sVEGFR-1 level in women with preeclampsia: A prospective controlled study. Journal of Turkish Society of Obstetric and Gynecology 19:4, pages 268-274.
Crossref
Crossref
Ravi Thadhani, Elizabeth Lemoine, Sarosh Rana, Maged M. Costantine, Vinicius F. Calsavara, Kim Boggess, Blair J. Wylie, Tiffany A. Moore Simas, Judette M. Louis, Jimmy Espinoza, Stephanie L. Gaw, Amy Murtha, Samantha Wiegand, Yvonne Gollin, Deepjot Singh, Robert M. Silver, Danielle E. Durie, Britta Panda, Errol R. Norwitz, Irina Burd, Beth Plunkett, Rachel K. Scott, Anna Gaden, Martha Bautista, Yuchiao Chang, Marcio A. Diniz, S. Ananth Karumanchi & Sarah Kilpatrick. (2022) Circulating Angiogenic Factor Levels in Hypertensive Disorders of Pregnancy. NEJM Evidence 1:12.
Crossref
Crossref
Adi L. Tarca, Roberto Romero, Gaurav Bhatti, Francesca Gotsch, Bogdan Done, Dereje W. Gudicha, Dahiana M. Gallo, Eunjung Jung, Roger Pique-Regi, Stanley M. Berry, Tinnakorn Chaiworapongsa & Nardhy Gomez-Lopez. (2022) Human Plasma Proteome During Normal Pregnancy. Journal of Proteome Research 21:11, pages 2687-2702.
Crossref
Crossref
Roberto Romero, Eunjung Jung, Tinnakorn Chaiworapongsa, Offer Erez, Dereje W. Gudicha, Yeon Mee Kim, Jung-Sun Kim, Bomi Kim, Juan Pedro Kusanovic, Francesca Gotsch, Andreea B. Taran, Bo Hyun Yoon, Sonia S. Hassan, Chaur-Dong Hsu, Piya Chaemsaithong, Nardhy Gomez-Lopez, Lami Yeo, Chong Jai Kim & Adi L. Tarca. (2022) Toward a new taxonomy of obstetrical disease: improved performance of maternal blood biomarkers for the great obstetrical syndromes when classified according to placental pathology. American Journal of Obstetrics and Gynecology 227:4, pages 615.e1-615.e25.
Crossref
Crossref
Leon J. Schmidt, Oliver Rieger, Mark Neznansky, Max Hackelöer, Lisa A. Dröge, Wolfgang Henrich, David Higgins & Stefan Verlohren. (2022) A machine-learning–based algorithm improves prediction of preeclampsia-associated adverse outcomes. American Journal of Obstetrics and Gynecology 227:1, pages 77.e1-77.e30.
Crossref
Crossref
Eunjung Jung, Roberto Romero, Lami Yeo, Nardhy Gomez-Lopez, Piya Chaemsaithong, Adithep Jaovisidha, Francesca Gotsch & Offer Erez. (2022) The etiology of preeclampsia. American Journal of Obstetrics and Gynecology 226:2, pages S844-S866.
Crossref
Crossref
Kelsey McLaughlin, Sebastian R. Hobson, Anjana Ravi Chandran, Swati Agrawal, Rory C. Windrim, W. Tony Parks, Adrian W. Bowman, Ulla Sovio, Gordon C. Smith & John C. Kingdom. (2022) Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction. American Journal of Obstetrics and Gynecology 226:2, pages S1145-S1156.e1.
Crossref
Crossref
Sarosh Rana, Suzanne D. Burke & S. Ananth Karumanchi. (2022) Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders. American Journal of Obstetrics and Gynecology 226:2, pages S1019-S1034.
Crossref
Crossref
Stefan Verlohren & Lisa-Antonia Dröge. (2022) The diagnostic value of angiogenic and antiangiogenic factors in differential diagnosis of preeclampsia. American Journal of Obstetrics and Gynecology 226:2, pages S1048-S1058.
Crossref
Crossref
Asim K. Duttaroy & Sanjay Basak. (2022) Maternal Fatty Acid Metabolism in Pregnancy and Its Consequences in the Feto-Placental Development. Frontiers in Physiology 12.
Crossref
Crossref
Adi L. Tarca, Andreea Taran, Roberto Romero, Eunjung Jung, Carmen Paredes, Gaurav Bhatti, Corina Ghita, Tinnakorn Chaiworapongsa, Nandor Gabor Than & Chaur-Dong Hsu. (2022) Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study. American Journal of Obstetrics and Gynecology 226:1, pages 126.e1-126.e22.
Crossref
Crossref
A Peguero, L Fernandez‐Blanco, E Mazarico, L Benitez, A Gonzalez, L Youssef, F Crispi, S Hernandez & F Figueras. (2020) Added prognostic value of longitudinal changes of angiogenic factors in early‐onset severe pre‐eclampsia: a prospective cohort study. BJOG: An International Journal of Obstetrics & Gynaecology 128:2, pages 158-165.
Crossref
Crossref
Sean Lim, Wentao Li, Jessica Kemper, Andrew Nguyen, Ben Willem Mol & Maya Reddy. (2021) Biomarkers and the Prediction of Adverse Outcomes in Preeclampsia. Obstetrics & Gynecology 137:1, pages 72-81.
Crossref
Crossref
U. Vivian Ukah, Beth A. Payne, Jennifer A. Hutcheon, Lucy C. Chappell, Paul T. Seed, Frances Inez Conti-Ramsden, J. Mark Ansermino, Laura A. Magee & Peter von Dadelszen. (2020) Placental growth factor for the prognosis of women with preeclampsia (fullPIERS model extension): context matters. BMC Pregnancy and Childbirth 20:1.
Crossref
Crossref
Sanjay Basak, Mrinal K. Das & Asim K. Duttaroy. (2020) Plastics derived endocrine‐disrupting compounds and their effects on early development. Birth Defects Research 112:17, pages 1308-1325.
Crossref
Crossref
José Pacheco-Romero, Oscar Acosta Conchucos, Doris Huerta Canales, Santiago Cabrera Ramos, Marlene Vargas Chávez, Pedro Mascaro Sánchez, Moisés Huamán Guerrero, José Sandoval Paredes, Rudy López Gabriel, Julio Mateus, Enrique Gil Guevara, Enrique Guevara Ríos, Nitza Butrica Ferré, Diana Catari Soto, David Bellido Yarlequé, Gina Custodio Gonzales & Andrea Naranjo Andonaire. (2020) Genetic markers for preeclampsia in Peruvian women. Colombia Medica.
Crossref
Crossref
David Wright, Alan Wright & Kypros H. Nicolaides. (2020) The competing risk approach for prediction of preeclampsia. American Journal of Obstetrics and Gynecology 223:1, pages 12-23.e7.
Crossref
Crossref
Asim K. Duttaroy & Sanjay Basak. (2020) Maternal dietary fatty acids and their roles in human placental development. Prostaglandins, Leukotrienes and Essential Fatty Acids 155, pages 102080.
Crossref
Crossref
Kelly-Ann Eastwood, Alyson J Hunter, Christopher C Patterson, David R Mc Cance, Ian S Young & Valerie A Holmes. (2019) The role of biomarkers in predicting pre-eclampsia in high-risk women. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 57:2, pages 128-137.
Crossref
Crossref
Karoline Mayer-Pickel, Vassiliki Kolovetsiou-Kreiner, Christina Stern, Julia Münzker, Katharina Eberhard, Slave Trajanoski, Ioana-Claudia Lakovschek, Daniela Ulrich, Bence Csapo, Uwe Lang, Barbara Obermayer-Pietsch & Mila Cervar-Zivkovic. (2019) Effect of Low-Dose Aspirin on Soluble FMS-Like Tyrosine Kinase 1/Placental Growth Factor (sFlt-1/PlGF Ratio) in Pregnancies at High Risk for the Development of Preeclampsia. Journal of Clinical Medicine 8:9, pages 1429.
Crossref
Crossref
Takuji Tomimatsu, Kazuya Mimura, Shinya Matsuzaki, Masayuki Endo, Keiichi Kumasawa & Tadashi Kimura. (2019) Preeclampsia: Maternal Systemic Vascular Disorder Caused by Generalized Endothelial Dysfunction Due to Placental Antiangiogenic Factors. International Journal of Molecular Sciences 20:17, pages 4246.
Crossref
Crossref
Anca Ciobanu, Alan Wright, Anca Panaitescu, Argyro Syngelaki, David Wright & Kypros H. Nicolaides. (2019) Prediction of imminent preeclampsia at 35–37 weeks gestation. American Journal of Obstetrics and Gynecology 220:6, pages 584.e1-584.e11.
Crossref
Crossref
Sarosh Rana, Saira Salahuddin, Ariel Mueller, Anders H. Berg, Ravi I. Thadhani & S. Ananth Karumanchi. (2018) Angiogenic biomarkers in triage and risk for preeclampsia with severe features. Pregnancy Hypertension 13, pages 100-106.
Crossref
Crossref
E. Sabriá, P. Lequerica-Fernández, P. Lafuente-Ganuza, E. Eguia-Ángeles, A. I. Escudero, E. Martínez-Morillo, C. Barceló & F. V. Álvarez. (2018) Addition of N-terminal pro-B natriuretic peptide to soluble fms-like tyrosine kinase-1/placental growth factor ratio > 38 improves prediction of pre-eclampsia requiring delivery within 1 week: a longitudinal cohort study. Ultrasound in Obstetrics & Gynecology 51:6, pages 758-767.
Crossref
Crossref
Reema Kumar Bhatt & K. Aparna Sharma. (2017) Screening for Preeclampsia. Journal of Fetal Medicine 5:1, pages 31-36.
Crossref
Crossref
Swati AgrawalAna Sofia CerdeiraChristopher RedmanManu Vatish. (2018) Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia. Hypertension 71:2, pages 306-316.
Crossref
Crossref
U. Vivian UkahJennifer A. HutcheonBeth PayneMatthew D. HaslamManu VatishJ. Mark AnserminoHelen BrownLaura A. MageePeter von Dadelszen. (2017) Placental Growth Factor as a Prognostic Tool in Women With Hypertensive Disorders of Pregnancy. Hypertension 70:6, pages 1228-1237.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Offer Erez, Adi L. Tarca, Agustin Conde-Agudelo, Piya Chaemsaithong, Chong Jai Kim, Yeon Mee Kim, Jung-Sun Kim, Bo Hyun Yoon, Sonia S. Hassan, Lami Yeo & Steven J. Korzeniewski. (2017) The prediction of fetal death with a simple maternal blood test at 24-28 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio). American Journal of Obstetrics and Gynecology 217:6, pages 682.e1-682.e13.
Crossref
Crossref
Roberto Romero, Offer Erez, Maik Hüttemann, Eli Maymon, Bogdan Panaitescu, Agustin Conde-Agudelo, Percy Pacora, Bo Hyun Yoon & Lawrence I. Grossman. (2017) Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity. American Journal of Obstetrics and Gynecology 217:3, pages 282-302.
Crossref
Crossref
Offer Erez, Roberto Romero, Eli Maymon, Piya Chaemsaithong, Bogdan Done, Percy Pacora, Bogdan Panaitescu, Tinnakorn Chaiworapongsa, Sonia S. Hassan & Adi L. Tarca. (2017) The prediction of late-onset preeclampsia: Results from a longitudinal proteomics study. PLOS ONE 12:7, pages e0181468.
Crossref
Crossref
Roberto Romero, Offer Erez, Eli Maymon, Piya Chaemsaithong, Zhonghui Xu, Percy Pacora, Tinnakorn Chaiworapongsa, Bogdan Done, Sonia S. Hassan & Adi L. Tarca. (2017) The maternal plasma proteome changes as a function of gestational age in normal pregnancy: a longitudinal study. American Journal of Obstetrics and Gynecology 217:1, pages 67.e1-67.e21.
Crossref
Crossref
Takuji Tomimatsu, Kazuya Mimura, Masayuki Endo, Keiichi Kumasawa & Tadashi Kimura. (2016) Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction. Hypertension Research 40:4, pages 305-310.
Crossref
Crossref
Carlos A. Labarrere, Hector L. DiCarlo, Elaine Bammerlin, James W. Hardin, Yeon M. Kim, Piya Chaemsaithong, David M. Haas, Ghassan S. Kassab & Roberto Romero. (2017) Failure of physiologic transformation of spiral arteries, endothelial and trophoblast cell activation, and acute atherosis in the basal plate of the placenta. American Journal of Obstetrics and Gynecology 216:3, pages 287.e1-287.e16.
Crossref
Crossref
I. Dragan, D. Wright, M. Fiolna, G. Leipold & K. H. Nicolaides. (2017)
Development of pre-eclampsia within 4 weeks of sFlt-1/PlGF ratio > 38: comparison of performance at 31-34
vs
35-37 weeks' gestation
. Ultrasound in Obstetrics & Gynecology 49:2, pages 209-212.
Crossref
Crossref
D. Wright, I. Dragan, A. Syngelaki, R. Akolekar & K. H. Nicolaides. (2017) Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks' gestation. Ultrasound in Obstetrics & Gynecology 49:2, pages 194-200.
Crossref
Crossref
M. Y. Tan, D. Wright, L. Koutoulas, R. Akolekar & K. H. Nicolaides. (2017) Comparison of screening for pre-eclampsia at 31-34 weeks' gestation by sFlt-1/PlGF ratio and a method combining maternal factors with sFlt-1 and PlGF. Ultrasound in Obstetrics & Gynecology 49:2, pages 201-208.
Crossref
Crossref
I. Dragan, T. Georgiou, N. Prodan, R. Akolekar & K. H. Nicolaides. (2017) Screening for pre-eclampsia using sFlt-1/PlGF ratio cut-off of 38 at 30-37 weeks' gestation. Ultrasound in Obstetrics & Gynecology 49:1, pages 73-77.
Crossref
Crossref
Indira Álvarez-Fernández, Belén Prieto, Verónica Rodríguez, Yolanda Ruano, Ana I. Escudero & Francisco V. Álvarez. (2016) N-terminal pro B-type natriuretic peptide and angiogenic biomarkers in the prognosis of adverse outcomes in women with suspected preeclampsia. Clinica Chimica Acta 463, pages 150-157.
Crossref
Crossref
Geoff K Frampton, Jeremy Jones, Micah Rose & Liz Payne. (2016) Placental growth factor (alone or in combination with soluble fms-like tyrosine kinase 1) as an aid to the assessment of women with suspected pre-eclampsia: systematic review and economic analysis. Health Technology Assessment 20:87, pages 1-160.
Crossref
Crossref
Suzy Duckworth, Lucy C. Chappell, Paul T. Seed, Lucy Mackillop, Andrew H. Shennan & Rachael Hunter. (2016) Placental Growth Factor (PlGF) in Women with Suspected Pre-Eclampsia Prior to 35 Weeks’ Gestation: A Budget Impact Analysis. PLOS ONE 11:10, pages e0164276.
Crossref
Crossref
Suzy Duckworth, Melanie Griffin, Paul T. Seed, Robyn North, Jenny Myers, Lucy Mackillop, Nigel Simpson, Jason Waugh, Dilly Anumba, Louise C. Kenny, Christopher W. G. Redman, Andrew H. Shennan & Lucy C. Chappell. (2016) Diagnostic Biomarkers in Women With Suspected Preeclampsia in a Prospective Multicenter Study. Obstetrics & Gynecology 128:2, pages 245-252.
Crossref
Crossref
Andreas Tsiakkas, Youssef Saiid, Alan Wright, David Wright & Kypros H. Nicolaides. (2016) Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30–34 weeks’ gestation. American Journal of Obstetrics and Gynecology 215:1, pages 87.e1-87.e17.
Crossref
Crossref
S. Andrietti, M. Silva, A. Wright, D. Wright & K. H. Nicolaides. (2016) Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks' gestation. Ultrasound in Obstetrics & Gynecology 48:1, pages 72-79.
Crossref
Crossref
D. Wright, K. Krajewska, A. Bogdanova, A. Wright & K. H. Nicolaides. (2016) Maternal serum soluble fms-like tyrosine kinase-1 at 22 and 32 weeks in the prediction of pre-eclampsia. Ultrasound in Obstetrics & Gynecology 47:6, pages 755-761.
Crossref
Crossref
Steven J. Korzeniewski, Roberto Romero, Tinnakorn Chaiworapongsa, Piya Chaemsaithong, Chong Jai Kim, Yeon Mee Kim, Jung-Sun Kim, Bo Hyun Yoon, Sonia S. Hassan & Lami Yeo. (2016) Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study. American Journal of Obstetrics and Gynecology 214:5, pages 629.e1-629.e17.
Crossref
Crossref
A. Tsiakkas, O. Mendez, A. Wright, D. Wright & K. H. Nicolaides. (2016) Maternal serum soluble fms-like tyrosine kinase-1 at 12, 22, 32 and 36 weeks' gestation in screening for pre-eclampsia. Ultrasound in Obstetrics & Gynecology 47:4, pages 478-483.
Crossref
Crossref
Carlos A. Escudero, Kurt Herlitz, Felipe Troncoso, Jesenia Acurio, Claudio Aguayo, James M. Roberts, Grace Truong, Gregory Duncombe, Gregory Rice & Carlos Salomon. (2016) Role of Extracellular Vesicles and microRNAs on Dysfunctional Angiogenesis during Preeclamptic Pregnancies. Frontiers in Physiology 7.
Crossref
Crossref
A. Khalil, N. Maiz, R. Garcia-Mandujano, J. M. Penco & K. H. Nicolaides. (2016) Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia. Ultrasound in Obstetrics & Gynecology 47:3, pages 324-331.
Crossref
Crossref
A. Margossian, C. Boisson-Gaudin, F. Subtil, R.-C. Rudigoz, G. Dubernard, F. Allias & C. Huissoud. (2016) Impact du retard de croissance intra-utérin sur la concentration sérique maternelle du PlGF (Placental Growth Factor) : une étude cas-témoin. Gynécologie Obstétrique & Fertilité 44:1, pages 23-28.
Crossref
Crossref
Lene G. Rasmussen, Jacob A. Lykke & Anne C. Staff. (2015) Angiogenic biomarkers in pregnancy: defining maternal and fetal health. Acta Obstetricia et Gynecologica Scandinavica 94:8, pages 820-832.
Crossref
Crossref
Melissa I. March, Carl Geahchan, Julia Wenger, Nandini Raghuraman, Anders Berg, Hamish Haddow, Bri Ann Mckeon, Rulx Narcisse, Jean Louis David, Jennifer Scott, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2015) Circulating Angiogenic Factors and the Risk of Adverse Outcomes among Haitian Women with Preeclampsia. PLOS ONE 10:5, pages e0126815.
Crossref
Crossref
A. Tsiakkas, N. Duvdevani, A. Wright, D. Wright & K. H. Nicolaides. (2015) Serum soluble fms-like tyrosine kinase-1 in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound in Obstetrics & Gynecology 45:5, pages 584-590.
Crossref
Crossref
A. Tsiakkas, N. Duvdevani, A. Wright, D. Wright & K. H. Nicolaides. (2015) Serum placental growth factor in the three trimesters of pregnancy: effects of maternal characteristics and medical history. Ultrasound in Obstetrics & Gynecology 45:5, pages 591-598.
Crossref
Crossref
Gabor Szalai, Roberto Romero, Tinnakorn Chaiworapongsa, Yi Xu, Bing Wang, Hyunyoung Ahn, Zhonghui Xu, Po Jen Chiang, Birgitta Sundell, Rona Wang, Yang Jiang, Olesya Plazyo, Mary Olive, Adi L. Tarca, Zhong Dong, Faisal Qureshi, Zoltan Papp, Sonia S. Hassan, Edgar Hernandez-Andrade & Nandor Gabor Than. (2015) Full-Length Human Placental sFlt-1-e15a Isoform Induces Distinct Maternal Phenotypes of Preeclampsia in Mice. PLOS ONE 10:4, pages e0119547.
Crossref
Crossref
Anita Pratt, Fabricio Da Silva Costa, Anthony J. Borg, Bill Kalionis, Rosemary Keogh & Padma Murthi. (2014) Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia. Angiogenesis 18:2, pages 115-123.
Crossref
Crossref
Glenn E. Palomaki, James E. Haddow, Hamish R. M. Haddow, Saira Salahuddin, Carl Geahchan, Ana Sofia Cerdeira, Stefan Verlohren, Frank H. Perschel, Gary Horowitz, Ravi Thadhani, S. Ananth Karumanchi & Sarosh Rana. (2015) Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia. Prenatal Diagnosis 35:4, pages 386-393.
Crossref
Crossref
H. Stepan, I. Herraiz, D. Schlembach, S. Verlohren, S. Brennecke, F. Chantraine, E. Klein, O. Lapaire, E. Llurba, A. Ramoni, M. Vatish, D. Wertaschnigg & A. Galindo. (2015)
Implementation of the
sFlt
‐1/
PlGF
ratio for prediction and diagnosis of pre‐eclampsia in singleton pregnancy: implications for clinical practice
. Ultrasound in Obstetrics & Gynecology 45:3, pages 241-246.
Crossref
Crossref
S. Ananth Karumanchi, Sarosh Rana & Robert N. Taylor. 2015. Chesley's Hypertensive Disorders in Pregnancy. Chesley's Hypertensive Disorders in Pregnancy
113
132
.
Gabor Szalai, Yi Xu, Roberto Romero, Tinnakorn Chaiworapongsa, Zhonghui Xu, Po Jen Chiang, Hyunyoung Ahn, Birgitta Sundell, Olesya Plazyo, Yang Jiang, Mary Olive, Bing Wang, Suzanne M. Jacques, Faisal Qureshi, Adi L. Tarca, Offer Erez, Zhong Dong, Zoltan Papp, Sonia S. Hassan, Edgar Hernandez-Andrade & Nandor Gabor Than. (2014) In Vivo Experiments Reveal the Good, the Bad and the Ugly Faces of sFlt-1 in Pregnancy. PLoS ONE 9:11, pages e110867.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Piya Chaemsaithong, Steven J. Korzeniewski, Lami Yeo & Roberto Romero. (2014) Pre-eclampsia part 2: prediction, prevention and management. Nature Reviews Nephrology 10:9, pages 531-540.
Crossref
Crossref
Leona C. Poon & Kypros H. Nicolaides. (2014) First-trimester maternal factors and biomarker screening for preeclampsia. Prenatal Diagnosis 34:7, pages 618-627.
Crossref
Crossref
Eva Meler, Elena Scazzocchio, Anna Peguero, Stefania Triunfo, Eduard Gratacos & Francesc Figueras. (2014) Role of maternal plasma levels of placental growth factor for the prediction of maternal complications in preeclampsia according to the gestational age at onset. Prenatal Diagnosis 34:7, pages 706-710.
Crossref
Crossref
Zeynep Alpay Savasan, Luis F. Goncalves & Ray O. Bahado-Singh. (2014) Second- and third-trimester biochemical and ultrasound markers predictive of ischemic placental disease. Seminars in Perinatology 38:3, pages 167-176.
Crossref
Crossref
Sarosh RanaS. Ananth KarumanchiMarshall D. Lindheimer. (2014) Angiogenic Factors in Diagnosis, Management, and Research in Preeclampsia. Hypertension 63:2, pages 198-202.
Crossref
Crossref
JIMMY ESPINOZA. (2014) ANGIOGENIC IMBALANCES IN THE PATHOGENESIS OF PREGNANCY COMPLICATIONS. Fetal and Maternal Medicine Review 25:1, pages 42-58.
Crossref
Crossref
Santiago Garcia-Tizon Larroca, Ahmet Tayyar, Leona C. Poon, David Wright & Kypros H. Nicolaides. (2014) Competing Risks Model in Screening for Preeclampsia by Biophysical and Biochemical Markers at 30-33 Weeks' Gestation. Fetal Diagnosis and Therapy 36:1, pages 9-17.
Crossref
Crossref
Jonathan Lai, Santiago Garcia-Tizon Larroca, Gergana Peeva, Leona C. Poon, David Wright & Kypros H. Nicolaides. (2014) Competing Risks Model in Screening for Preeclampsia by Serum Placental Growth Factor and Soluble fms-Like Tyrosine Kinase-1 at 30-33 Weeks' Gestation. Fetal Diagnosis and Therapy 35:4, pages 240-248.
Crossref
Crossref
Leona C. Poon & Kypros H. Nicolaides. (2014) Early Prediction of Preeclampsia. Obstetrics and Gynecology International 2014, pages 1-11.
Crossref
Crossref
Pia M Villa, Esa Hämäläinen, Annukka Mäki, Katri Räikkönen, Anu-Katriina Pesonen, Pekka Taipale, Eero Kajantie & Hannele Laivuori. (2013) Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort. BMC Pregnancy and Childbirth 13:1.
Crossref
Crossref
Sanjay Basak, Mrinal K. Das & Asim K. Duttaroy. (2013) Fatty acid-induced angiogenesis in first trimester placental trophoblast cells: Possible roles of cellular fatty acid-binding proteins. Life Sciences 93:21, pages 755-762.
Crossref
Crossref
WT Schnettler, D Dukhovny, J Wenger, S Salahuddin, SJ Ralston & S Rana. (2013) Cost and resource implications with serum angiogenic factor estimation in the triage of pre-eclampsia. BJOG: An International Journal of Obstetrics & Gynaecology 120:10, pages 1224-1232.
Crossref
Crossref
Mihran V. Naljayan & S. Ananth Karumanchi. (2013) New Developments in the Pathogenesis of Preeclampsia. Advances in Chronic Kidney Disease 20:3, pages 265-270.
Crossref
Crossref
Nóra Gullai, Balázs Stenczer, Attila Molvarec, Gergely Fügedi, Zoltán Veresh, Bálint Nagy & János RigóJrJr. (2013) Evaluation of a rapid and simple placental growth factor test in hypertensive disorders of pregnancy. Hypertension Research 36:5, pages 457-462.
Crossref
Crossref
Sanjib Kumar Ghosh, Shashi Raheja, Anita Tuli, Chitra Raghunandan & Sneh Agarwal. (2012) Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?. Archives of Gynecology and Obstetrics 287:5, pages 865-873.
Crossref
Crossref
Craig Saffer, Gayle Olson, Kim A. Boggess, Richard Beyerlein, Charles Eubank & Baha M. Sibai. (2013) Determination of placental growth factor (PlGF) levels in healthy pregnant women without signs or symptoms of preeclampsia. Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health 3:2, pages 124-132.
Crossref
Crossref
Amy E. Whitten, Roberto Romero, Steven J. Korzeniewski, Adi L. Tarca, Alyse G. Schwartz, Lami Yeo, Zhong Dong, Sonia S. Hassan & Tinnakorn Chaiworapongsa. (2013) Evidence of an imbalance of angiogenic/antiangiogenic factors in massive perivillous fibrin deposition (maternal floor infarction): a placental lesion associated with recurrent miscarriage and fetal death. American Journal of Obstetrics and Gynecology 208:4, pages 310.e1-310.e11.
Crossref
Crossref
Tinnakorn Chaiworapongsa, Roberto Romero, Steven J. Korzeniewski, Juan Pedro Kusanovic, Eleazar Soto, Jennifer Lam, Zhong Dong, Nandor G. Than, Lami Yeo, Edgar Hernandez-Andrade, Agustín Conde-Agudelo & Sonia S. Hassan. (2013) Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia. American Journal of Obstetrics and Gynecology 208:4, pages 287.e1-287.e15.
Crossref
Crossref
Sun K. Kim, Roberto Romero, Zeynep A. Savasan, Yi Xu, Zhong Dong, Deug‐Chan Lee, Lami Yeo, Sonia S. Hassan & Tinnakorn Chaiworapongsa. (2012) Endoglin in Amniotic Fluid as a Risk Factor for the Subsequent Development of Bronchopulmonary Dysplasia. American Journal of Reproductive Immunology 69:2, pages 105-123.
Crossref
Crossref
Sanjay Basak & Asim K. Duttaroy. (2013) Effects of fatty acids on angiogenic activity in the placental extravillious trophoblast cells. Prostaglandins, Leukotrienes and Essential Fatty Acids 88:2, pages 155-162.
Crossref
Crossref
Jeanne Sibiude, Jean Guibourdenche, Marie-Danielle Dionne, Camille Le Ray, Olivia Anselem, Raphaël Serreau, François Goffinet & Vassilis Tsatsaris. (2012) Placental Growth Factor for the Prediction of Adverse Outcomes in Patients with Suspected Preeclampsia or Intrauterine Growth Restriction. PLoS ONE 7:11, pages e50208.
Crossref
Crossref
Sarosh Rana, Ana Sofia Cerdeira, Julia Wenger, Saira Salahuddin, Kee-Hak Lim, Steven J. Ralston, Ravi I. Thadhani & S. Ananth Karumanchi. (2012) Plasma Concentrations of Soluble Endoglin versus Standard Evaluation in Patients with Suspected Preeclampsia. PLoS ONE 7:10, pages e48259.
Crossref
Crossref
Sarosh RanaMichele R. HackerAnna Merport ModestSaira SalahuddinKee-Hak LimStefan VerlohrenFrank H. PerschelS. Ananth Karumanchi. (2012) Circulating Angiogenic Factors and Risk of Adverse Maternal and Perinatal Outcomes in Twin Pregnancies With Suspected Preeclampsia. Hypertension 60:2, pages 451-458.
Crossref
Crossref
Henning Hagmann, Ravi Thadhani, Thomas Benzing, S Ananth Karumanchi & Holger Stepan. (2012) The Promise of Angiogenic Markers for the Early Diagnosis and Prediction of Preeclampsia. Clinical Chemistry 58:5, pages 837-845.
Crossref
Crossref